Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden
· Delayed Price · Currency is SEK 7.90
+0.17 (2.20%)
Apr 25, 2025, 5:29 PM CET
Diamyd Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is September - August.
Millions SEK. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 28, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 103.75 | 112.76 | 127.53 | 119.76 | 139.38 | 58.37 | Upgrade
|
| Short-Term Investments | - | 19.61 | - | 39.91 | - | 10 | Upgrade
|
| Cash & Short-Term Investments | 103.75 | 132.37 | 127.53 | 159.67 | 139.38 | 68.36 | Upgrade
|
| Cash Growth | -24.35% | 3.79% | -20.13% | 14.56% | 103.88% | 20.54% | Upgrade
|
| Accounts Receivable | 0.1 | 0.02 | 0.06 | 0.25 | 0.05 | 0.08 | Upgrade
|
| Other Receivables | 3.16 | 3.99 | 4.61 | 2.23 | 1.59 | 3.6 | Upgrade
|
| Receivables | 3.26 | 4.02 | 4.67 | 2.48 | 1.65 | 3.68 | Upgrade
|
| Prepaid Expenses | 16.22 | 0.75 | 0.92 | 10.86 | 21.95 | 0.35 | Upgrade
|
| Other Current Assets | - | 22.01 | 7.69 | 0 | - | 0 | Upgrade
|
| Total Current Assets | 123.24 | 159.14 | 140.81 | 173.01 | 162.97 | 72.39 | Upgrade
|
| Property, Plant & Equipment | 49.28 | 49.36 | 52.32 | 45.75 | 5.55 | 1.97 | Upgrade
|
| Long-Term Investments | 7.9 | 7.9 | 10.57 | 15.46 | 32.22 | 14.57 | Upgrade
|
| Other Intangible Assets | - | - | - | - | 0.07 | 0.21 | Upgrade
|
| Long-Term Deferred Tax Assets | 0.24 | 0.3 | 1.54 | 1.68 | - | - | Upgrade
|
| Other Long-Term Assets | 0.22 | 0.34 | 0.57 | 0.63 | 0.63 | 0.63 | Upgrade
|
| Total Assets | 180.88 | 217.04 | 205.81 | 236.52 | 201.44 | 89.76 | Upgrade
|
| Accounts Payable | 11 | 16.61 | 4.89 | 9.78 | 5.57 | 7.25 | Upgrade
|
| Accrued Expenses | - | 14.5 | 5.54 | 4.97 | 4.79 | 8.54 | Upgrade
|
| Current Unearned Revenue | 6.6 | - | - | 0.06 | - | - | Upgrade
|
| Other Current Liabilities | 8.49 | 8.92 | 9.43 | 6.56 | 1.04 | 0.7 | Upgrade
|
| Total Current Liabilities | 26.09 | 40.03 | 19.85 | 21.37 | 11.4 | 16.5 | Upgrade
|
| Other Long-Term Liabilities | 42.99 | 30.67 | 15.87 | 0 | 0 | 0 | Upgrade
|
| Total Liabilities | 69.35 | 71.12 | 36.41 | 22.15 | 12.18 | 17.28 | Upgrade
|
| Common Stock | 10.56 | 10.11 | 8.7 | 7.8 | 7.26 | 7.02 | Upgrade
|
| Additional Paid-In Capital | 632.03 | 586.35 | 460.29 | 390.51 | 248.9 | 192.41 | Upgrade
|
| Retained Earnings | -531.06 | -450.54 | -299.59 | -183.93 | -66.9 | -126.94 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | -0 | 0 | Upgrade
|
| Shareholders' Equity | 111.53 | 145.92 | 169.4 | 214.38 | 189.26 | 72.49 | Upgrade
|
| Total Liabilities & Equity | 180.88 | 217.04 | 205.81 | 236.52 | 201.44 | 89.76 | Upgrade
|
| Net Cash (Debt) | 103.75 | 132.37 | 127.53 | 159.67 | 139.38 | 68.36 | Upgrade
|
| Net Cash Growth | -24.35% | 3.79% | -20.13% | 14.56% | 103.88% | 20.54% | Upgrade
|
| Net Cash Per Share | 1.03 | 1.40 | 1.63 | 2.09 | 2.00 | 0.99 | Upgrade
|
| Filing Date Shares Outstanding | 104.09 | 104.09 | 85.78 | 76.93 | 71.57 | 69.17 | Upgrade
|
| Total Common Shares Outstanding | 104.09 | 99.72 | 85.78 | 76.93 | 71.57 | 69.17 | Upgrade
|
| Working Capital | 97.14 | 119.12 | 120.96 | 151.64 | 151.57 | 55.9 | Upgrade
|
| Book Value Per Share | 1.07 | 1.46 | 1.97 | 2.79 | 2.64 | 1.05 | Upgrade
|
| Tangible Book Value | 111.53 | 145.92 | 169.4 | 214.38 | 189.19 | 72.28 | Upgrade
|
| Tangible Book Value Per Share | 1.07 | 1.46 | 1.97 | 2.79 | 2.64 | 1.05 | Upgrade
|
| Land | 41.47 | - | - | 24.48 | - | - | Upgrade
|
| Buildings | - | 39.84 | 32.2 | - | - | - | Upgrade
|
| Machinery | 30.99 | 29.67 | 28.87 | 27.38 | 7.34 | - | Upgrade
|
| Construction In Progress | 0.37 | 0.41 | 0.83 | - | - | - | Upgrade
|
Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.